Biotechnical Faculty, University of Ljubljana, Jamnikarjeva ulica 101, 1000, Ljubljana, Slovenia.
Faculty of Sport, University of Ljubljana, Gortanova ulica 22, 1000, Ljubljana, Slovenia.
Sports Med. 2024 May;54(5):1231-1247. doi: 10.1007/s40279-024-01992-8. Epub 2024 Feb 26.
Iron deficiency in athletes is initially treated with a nutritional intervention. If negative iron balance persists, oral iron supplementation (OIS) can be used. Despite the recent proposal for a refinement of treatment strategies for iron-deficient athletes, there is no general consensus regarding the actual efficiency, dosage, or optimal regimen of OIS.
The aim of this meta-analysis was to evaluate to what extent OIS affects blood iron parameters and physical performance in healthy adult athletes.
PubMed, Web of Science, PEDro, CINAHL, SPORTDiscus, and Cochrane were searched from inception to 2 November 2022. Articles were eligible if they satisfied the following criteria: recruited subjects were healthy, adult and physically active individuals, who used exclusively OIS, irrespective of sex and sports discipline.
simultaneous supplementation with iron and any other micronutrient(s), intravenous iron supplementation or recent exposure to altitude acclimatisation. The methodological quality of included studies was assessed with the PEDro scale, the completeness of intervention reporting with the TIDieR scale, while the GRADE scale was used for quality of evidence synthesis. The present study was prospectively registered in PROSPERO online registry (ID: CRD42022330230).
From 638 articles identified through the search, 13 studies (n = 449) were included in the quantitative synthesis. When compared to the control group, the results demonstrated that OIS increases serum ferritin (standardized mean difference (SMD) = 1.27, 95% CI 0.44-2.10, p = 0.006), whereas blood haemoglobin (SMD = 1.31, 95% CI - 0.29 to 2.93, p = 0.099), serum transferrin receptor concentration (SMD = - 0.74, 95% CI - 1.89 to 0.41, p = 0.133), and transferrin saturation (SMD = 0.69, 95% CI - 0.84 to 2.22, p = 0.330) remained unaltered. Following OIS, a trend of small positive effect on VO (SMD = 0.49, 95% CI - 0.09 to 1.07, p = 0.086) was observed in young healthy athletes. The quality of evidence for all outcomes ranged from moderate to low.
Increase in serum ferritin concentration after OIS was evident in subjects with initial pre-supplementation serum ferritin concentration ≤ 12 µg/l, while only minimal, if any effect, was observed in subjects with higher pre-supplementation serum ferritin concentration. The doses of OIS, that induced a beneficial effect on hematological parameters differed from 16 to 100 mg of elementary iron daily, over the period between 6 and 8 weeks. Shorter supplementation protocols have been shown to be ineffective.
运动员缺铁时,最初采用营养干预。若持续出现负铁平衡,可采用口服铁补充剂(OIS)。尽管最近提出了对缺铁运动员的治疗策略进行细化,但对于 OIS 的实际效率、剂量或最佳方案尚未达成普遍共识。
本荟萃分析旨在评估 OIS 对健康成年运动员的血液铁参数和身体表现的影响程度。
从建库至 2022 年 11 月 2 日,通过 PubMed、Web of Science、PEDro、CINAHL、SPORTDiscus 和 Cochrane 检索文献。符合以下标准的文章纳入分析:研究对象为健康的成年和活跃的个体,仅使用 OIS,无论其性别和运动项目如何。
同时补充铁和任何其他微量营养素、静脉铁补充或近期暴露于高原适应。使用 PEDro 量表评估纳入研究的方法学质量,使用 TIDieR 量表评估干预报告的完整性,使用 GRADE 量表评估证据综合质量。本研究前瞻性地在 PROSPERO 在线注册(ID:CRD42022330230)。
通过检索共确定了 638 篇文章,其中 13 项研究(n=449)纳入定量分析。与对照组相比,结果表明 OIS 可增加血清铁蛋白(标准化均数差(SMD)=1.27,95%置信区间(CI)0.44-2.10,p=0.006),而血红蛋白(SMD=1.31,95%CI -0.29 至 2.93,p=0.099)、血清转铁蛋白受体浓度(SMD=-0.74,95%CI -1.89 至 0.41,p=0.133)和转铁蛋白饱和度(SMD=0.69,95%CI -0.84 至 2.22,p=0.330)无明显变化。在接受 OIS 治疗后,年轻健康运动员的 VO2 呈小幅度的正趋势(SMD=0.49,95%CI -0.09 至 1.07,p=0.086)。所有结局的证据质量均为中至低。
在初始预补充血清铁蛋白浓度≤12μg/l 的受试者中,OIS 后血清铁蛋白浓度升高,但在预补充血清铁蛋白浓度较高的受试者中,OIS 仅表现出最小的(如果有的话)作用。诱导血液学参数产生有益影响的 OIS 剂量为 16 至 100mg 每日元素铁,持续 6 至 8 周。较短的补充方案显示无效。